(Q53338021)

13 May 2018

review article

1 reference

title

The tumour microenvironment as a target for chemoprevention. (English)

1 reference

13 May 2018

Adriana Albini

1

0 references

author name string

Michael B Sporn

series ordinal

2

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

13 May 2018

published in

Nature Reviews Cancer

1 reference

13 May 2018

volume

7

1 reference

13 May 2018

page(s)

139-147

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/nrc2067

exact match

0 references

cites work

The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression

1 reference

31 March 2020

1 reference

Friends or foes - bipolar effects of the tumour stroma in cancer

31 March 2020

1 reference

Therapeutic targeting of the tumor microenvironment

31 March 2020

1 reference

Stromal fibroblasts in cancer initiation and progression

31 March 2020

1 reference

Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes

31 March 2020

1 reference

Angiogenesis: update 2005.

31 March 2020

1 reference

Tumor inflammatory angiogenesis and its chemoprevention

31 March 2020

1 reference

Inflammation and cancer: the long reach of Ras

31 March 2020

1 reference

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

31 March 2020

1 reference

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

31 March 2020

1 reference

Distinct role of macrophages in different tumor microenvironments

31 March 2020

1 reference

Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway

31 March 2020

1 reference

Neutrophils and angiogenesis: potential initiators of the angiogenic cascade

31 March 2020

1 reference

Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.

31 March 2020

1 reference

CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A.

31 March 2020

1 reference

31 March 2020

Fibroblasts in cancer

1 reference

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

31 March 2020

1 reference

Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis

31 March 2020

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

31 March 2020

1 reference

31 March 2020

1 reference

Inflammation, stress, and diabetes

31 March 2020

1 reference

Cancer: the matrix is now in control

31 March 2020

1 reference

Inductive tissue interaction in development

31 March 2020

1 reference

Stromal effects on mammary gland development and breast cancer

31 March 2020

1 reference

Molecular characterization of the tumor microenvironment in breast cancer

31 March 2020

1 reference

Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas

31 March 2020

1 reference

Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.

31 March 2020

1 reference

Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas

31 March 2020

1 reference

A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities

31 March 2020

1 reference

Smad4 signalling in T cells is required for suppression of gastrointestinal cancer.

31 March 2020

1 reference

Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis

31 March 2020

1 reference

Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture

31 March 2020

1 reference

Overview of mechanisms of cancer chemopreventive agents

31 March 2020

1 reference

Cancer chemoprevention: scientific promise, clinical uncertainty

31 March 2020

1 reference

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward

31 March 2020

1 reference

31 March 2020

Inflammation and cancer

1 reference

Cancer and the chemokine network

31 March 2020

1 reference

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

31 March 2020

1 reference

NF-kappaB: linking inflammation and immunity to cancer development and progression

31 March 2020

1 reference

Mechanisms of disease: Inflammatory mediators and cancer prevention

31 March 2020

1 reference

The STATs of cancer--new molecular targets come of age

31 March 2020

1 reference

The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells

31 March 2020

1 reference

Stat3 regulates genes common to both wound healing and cancer

31 March 2020

1 reference

NF-kappaB and cancer: mechanisms and targets

31 March 2020

1 reference

Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses

31 March 2020

1 reference

Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy

31 March 2020

1 reference

Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets

31 March 2020

1 reference

Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention.

31 March 2020

1 reference

Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.

31 March 2020

1 reference

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

31 March 2020

1 reference

The Survivin saga goes in vivo

31 March 2020

1 reference

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

31 March 2020

1 reference

Control of apoptosis during angiogenesis by survivin expression in endothelial cells

31 March 2020

1 reference

Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents

31 March 2020

1 reference

The hypoxia-inducible factor and tumor progression along the angiogenic pathway.

31 March 2020

1 reference

HIF, a missing link between metabolism and cancer

31 March 2020

1 reference

Hypoxia, clonal selection, and the role of HIF-1 in tumor progression

31 March 2020

1 reference

HIF-1alpha is essential for myeloid cell-mediated inflammation

31 March 2020

1 reference

Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice

31 March 2020

1 reference

The epigenome as a target for cancer chemoprevention

31 March 2020

1 reference

Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha

31 March 2020

1 reference

Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha

31 March 2020

1 reference

Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.

31 March 2020

1 reference

Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells

31 March 2020

1 reference

Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways.

31 March 2020

1 reference

Targeting HIF-1 for cancer therapy

31 March 2020

1 reference

The hypoxic response of tumors is dependent on their microenvironment.

31 March 2020

1 reference

Genetic evidence for a tumor suppressor role of HIF-2alpha.

31 March 2020

1 reference

Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis

31 March 2020

1 reference

Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications

31 March 2020

1 reference

Nrf2 as a novel molecular target for chemoprevention

31 March 2020

1 reference

Transcriptional regulation of vascular endothelial growth factor in cancer.

31 March 2020

1 reference

A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours

31 March 2020

1 reference

Transplacental carcinogenesis by stilbestrol

31 March 2020

1 reference

Angiogenesis in life, disease and medicine

31 March 2020

1 reference

Antiangiogenic therapy: a universal chemosensitization strategy for cancer?

31 March 2020

1 reference

COX-2: a molecular target for colorectal cancer prevention

31 March 2020

1 reference

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

31 March 2020

1 reference

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

31 March 2020

1 reference

Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis

31 March 2020

1 reference

The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide

31 March 2020

1 reference

N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products

31 March 2020

1 reference

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

31 March 2020

1 reference

Statins and cancer prevention

31 March 2020

1 reference

Celecoxib for the prevention of colorectal adenomatous polyps

31 March 2020

1 reference

Celecoxib for the prevention of sporadic colorectal adenomas

31 March 2020

1 reference

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

31 March 2020

1 reference

Validating and improving models for projecting the absolute risk of breast cancer

31 March 2020

1 reference

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention

31 March 2020

1 reference

Selecting targets for cancer prevention: where do we go from here?

31 March 2020

1 reference

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

31 March 2020

1 reference

Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC2067

1 reference

13 May 2018

PubMed ID

17218951

1 reference

13 May 2018